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A nose for trouble
A 63‑year‑old Caucasian non‑smoker presented with 
purplish, firm, slowly growing plaques on the nose, 
of 20 years duration. The bigger one involved the 
upper part of the nose in its entirety [Figure 1], while 
there were smaller ones on the left and right cheek. All 
the plaques were asymptomatic and did not worsen 
after sunlight exposure. His past medical history 
was unremarkable. Hematological and biochemical 
parameters were within normal limits. Histological 
examination revealed a diffuse mid‑dermal cellular 
infiltrate composed of neutrophils, eosinophils, 
plasma cells, and lymphocytes. A narrow Grenz 
zone was present. In the lower part of the reticular 
dermis, the mixed infiltrate was intermingled with 
a massive deposition of fascicled pattern collagen 
fibers and spindle cells [Figures 2 and 3].
WHAT IS YOUR DIAGNOSIS?
Quiz
Figure 1: Erythematous indurated plaque of the upper nose Figure 2: A narrow Grenz zone and superficial and deep inflitrates 
are noted. (H and E, ×4)
Figure 3: The infiltrate shows many eosinophils along with 
neutrophils, lymphocytes and plasma cells. Fascicles of spindle 
cells are also seen. (H and E, ×40)
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ANSWER
Diagnosis
Granuloma faciale
DISCUSSION
Granuloma faciale is an uncommon, benign, chronic 
inflammatory skin disease. It is characterized by 
recurrent erythematous papules, which evolve to 
nodules and/or plaques.[1] Over 90% of the cases 
occur in middle‑aged Caucasians, with the face being 
typically the site of onset. Multiple lesions develop in 
up to a third of patients, while extrafacial involvement 
occasionally occurs, usually several months to years 
after the onset.[2]
The aetiology is unknown, although different 
predisposing factors have been postulated, including 
radiation, trauma, and allergy.[1] The histopathology 
is diagnostic and shows a dense mid‑dermal cellular 
infiltrate rich in eosinophils, with a sub‑epidermal 
Grenz zone, leukocytoclastic vasculitis, and 
fibrosis.[3] The name of the disease was proposed 
by Pinkus, although it was first described by Lever 
and Leeper in 1950.[1] Histologically, there is no 
granulomatous inflammation, thus the term is 
actually a misnomer. The differential diagnosis 
includes discoid lupus erythematosus, deep mycotic 
infections, sarcoidosis, lymphoma, and fixed drug 
eruption.[4]
Numerous therapies have been tried for granuloma 
faciale, such as dapsone, several immunosuppressive 
drugs, topical calcineurin  inhibitors, dye lasers, 
surgical excision,[4] topical psoralen and UVA,[5] 
and intralesional corticosteroid injection, alone or 
combined with cryotherapy.[6] However, granuloma 
faciale is notoriously resistant to therapy and has a high 
rate of relapse. In our patient, therapy with dapsone, 
100 mg a day for 6 months, and tacrolimus ointment 
0.1%, twice daily for 2 months, had failed. Intralesional 
steroid injection of betamethasone at a dosage of 
6 mg every 2 weeks for 2 months caused the lesion to 
regress with  acceptable cosmetic improvement and 
without significant side effects [Figure 4]. No relapses 
occurred during a follow‑up period of 2 years.
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*****Figure 4: After the treatment with intralesional corticosteroid 
therapy
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